| 英文别名 |
Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate;4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester;Benzoicacid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, methyl ester;METHYL 4-METHYL-3-(4-(PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)BENZOATE;methyl 4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoate;Everolimus;Methyl 4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate;917392-54-2;DB-079163;Methyl4-Methyl-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzoate;UNII-HKX2YWY42Y;CS-0321831;NS00008500;Methyl 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic Acid Ester; Benzoic acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, methyl ester; Methyl 4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate; Methyl 4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate; Nilotinib methyl ester;AKOS015917907;NILOTINIB HYDROCHLORIDE MONOHYDRATE IMPURITY G [EP IMPURITY];METHYL 4-METHYL-3-{[4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}BENZOATE;BECBKQYLJDEVDN-UHFFFAOYSA-N;4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzoic acid methyl ester;HKX2YWY42Y;SCHEMBL534524;DTXSID40589940;EC 700-542-4;MFCD16619370 |